Back to News & Updates

AgaMatrix and LifeWallet Partner to Facilitate Prevention Care and Remote Monitoring in Populations at Risk of Developing Diabetes

Written by: Juleen Ginty
AgaMatrix and LifeWallet Partner to Facilitate Prevention Care and Remote Monitoring in Populations at Risk of Developing Diabetes

Salem, NH, July 25, 2017 – AgaMatrix and LifeWallet announce a collaboration to bring AgaMatrix’s accurate, connected blood glucose monitoring solutions together with LifeWallet’s intuitive apps for health risk assessment and follow up care, for improved outcomes in population health management.

According to the Centers for Disease Control and Prevention more than 1 out of 3 American adults have prediabetes (a precursor to diabetes) and 9 out of 10 do not know they have it. The AgaMatrix-LifeWallet integration aims to enhance preventative care for people at risk of developing diabetes by facilitating early detection and referral of care, coupled with remote monitoring and clinical support.

LifeWallet is currently piloting this innovative approach to preventative diabetes population health management in collaboration with West Kendall Baptist Hospital, as part of the GE-backed HealthyCities Leadership Academy Open Innovation Challenge.

Participants in their Sugar Smart for Life Program undergo a health risk assessment to establish their prediabetes risk. Patients whose levels fell within a pre-diabetic range received wearables and connected devices to capture data such as blood glucose, through AgaMatrix’s Bluetooth® enabled Jazz Wireless 2 Blood Glucose Meter, to understand the impact clinical remote monitoring and engagement may have on reducing blood glucose levels.

“By incorporating our glucose monitor into LifeWallet’s app ecosystem, it reduces the inefficiencies of traditional manual entry–providing a simplified testing experience for users that is intelligently designed to collect data with minimal disruption,” said John Alberico, President and CEO of AgaMatrix.

The data from the AgaMatrix Jazz Wireless 2 Meter easily integrates with LifeWallet apps through HealthKit, with over two thousand glucose data points collected in the first two months of the program.

“We were thrilled at the adoption of AgaMatrix’s Jazz Wireless 2 among participants in the GE Sugar Smart for Life Program, as more than 99.8% of the glucose readings were captured through the Jazz Wireless 2 device versus manually,” shared Norb Menendez, CEO, LifeWallet.

Clinicians can monitor patients’ daily habits and compliance to their tailored care plan as well as provide messages to help them stay on track, through LifeWallet’s Engage App. The Sugar Smart for Life Program will continue through October 2017.

For more information about AgaMatrix, visit www.agamatrix.com
For more information about LifeWallet, visit www.lifewallet.com

About AgaMatrix
AgaMatrix is a New Hampshire-based company that develops, manufactures, and markets innovative solutions for blood glucose monitoring and data management on mobile and cloud platforms. AgaMatrix products are powered by WaveSense, a suite of patented technologies that uniquely apply Dynamic Electrochemistry in blood glucose measurement, for accurate results. To learn more about the AgaMatrix Jazz Wireless 2 Blood Glucose Monitoring System visit www.agamatrix.com

About LifeWallet
LifeWallet™ is revolutionizing engagement and transforming the delivery of healthcare with digital health assistants that provide employers, communities, and healthcare professionals with simple, powerful solutions to assess the health of their population and monitor their progress towards better health outcomes. For more information, visit www.lifewallet.com

Written by: Juleen Ginty

Is a marketing and design strategist with a focus on building brands, digital content, and thoughtful product design for the healthcare industry. She has a passion for marrying creativity with complex, technical fields and helped launch medical devices through Sanofi, CVS, Target, AgaMatrix, and other consumer brands. Growing up with a family member who was diagnosed with type 1 diabetes, Juleen dove into understanding the diabetes industry, advances in technology, and patient perspective for the past 12 years, with the goal of delivering solutions that improve the way people manage their health.

We're looking for talented, passionate people to join our team.
View Careers